Document is current
Any future updates will be listed below
-
Authors
Ramos, Yolande F. M. https://orcid.org/0000-0003-1459-413X
Tertel, Tobias https://orcid.org/0000-0001-8659-8610
Shaw, Georgina
Staubach, Simon https://orcid.org/0000-0002-4317-9261
de Almeida, Rodrigo Coutinho https://orcid.org/0000-0001-7966-056X
Suchiman, Eka https://orcid.org/0000-0002-7168-5516
Kuipers, Thomas B. https://orcid.org/0000-0001-5994-1970
Mei, Hailiang
Barry, Frank https://orcid.org/0000-0002-5535-002X
Murphy, Mary https://orcid.org/0000-0003-0971-7684
Giebel, Bernd https://orcid.org/0000-0003-2446-948X
Meulenbelt, Ingrid https://orcid.org/0000-0001-7786-7081
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (874671, 667932)
RegMed 4D
- License Information
-
More Information
Article History
Received: 18 May 2022
Accepted: 4 August 2022
First Online: 2 September 2022
Declarations
:
: The Medical Ethics Committee of the LUMC gave approval for generation of hiPSCs from skin fibroblasts of healthy donors (P13.080). The Clinical Research Ethical Committee at University College Hospital, Galway, Ireland, provided approval for collection of bone marrow aspirates from healthy donors. The Medical Ethical Committee of the LUMC provided approval for collection of hBMSCs within the ongoing RAAK study and is available under numbers P08.239 and P19.013. Informed consent was obtained from all donors.
: Not applicable.
: BG is a scientific advisory board member of Innovex Therapeutics SL and Mursla Ltd. and a founding director of Exosla Ltd. None of the other authors report conflicts of interest.
